ADDF-Harrington Scholar Program

2022 Request for Proposals

The ADDF-Harrington Scholar Program is dedicated to advancing academic discoveries into medicines for Alzheimer’s disease and related dementias. This unique award provides funding and committed project support by a team of pharmaceutical industry experts through a collaboration with the Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute



  • Academic investigators at accredited medical centers, research institutions, and universities in the United States, Canada and United Kingdom only are eligible to apply.
  • Lead investigator must have an MD, a PhD, or equivalent.
  • Proposals should show potential to advance discovery into meaningful therapeutics to treat, prevent, or slow Alzheimer’s disease or related dementias.
  • Team should possess intellectual property (IP) or have potential for novel IP that has not yet been licensed to a for-profit entity.
  • Researchers working on drug development programs that are relevant to but not presently focused on the Alzheimer’s field are encouraged to apply.

*** Intellectual Property: We encourage the PI to contact the SFU’s Technology Licensing Office( to discuss all aspects of Intellectual Property relating to this call.



Award recipients will receive financial support up to $600,000 over two years, as well as dedicated drug development and project management support. 


How to apply:

Review the Application Instructions for steps on applying.

Two-step application process:

July 18th, 2022, 5:00 PM EDT LOI Deadline. Applicant (not ORS) submits LOI to agency.
October 24th, 2022, 5:00 PM EDT  Full proposal Application Deadline. SFU Signature Sheet and copy of full application due to Research Services no later than 3 business days before agency deadline


For full application details and deadlines, please see the  Alzheimer’s Drug Discovery Foundation website and  Guidelines.

For application submission inquiries, please

Upcoming Deadlines